Cdc7-IN-4
Cdc7-IN-4 (compound I-C) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-C. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1].
Product Specifications
CAS Number
1402059-21-5
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdc7-in-4.html
Solubility
10 mM in DMSO
Smiles
O=C(C(C/1=O)=C(NN2CCN(CC(F)(F)F)CC2)OC1=C/C3=CNC4=NC=CC=C43)OC(C)C
Molecular Formula
C22H24F3N5O4
Molecular Weight
479.45
References & Citations
[1]Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx274834-01 100 Tests
Matrix Metalloproteinase-9 (MMP9) Antibody (FITC)
Sign In for Pricing
View Details abx274834-02 200 Tests
Matrix Metalloproteinase-9 (MMP9) Antibody (FITC)
Sign In for Pricing
View Details abx274834-03 500 Tests
Matrix Metalloproteinase-9 (MMP9) Antibody (FITC)
Sign In for Pricing
View Details 